Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | CardiaLen Awarded Phase I SBIR GrantCardiac arrhythmia start-up awarded $216,027 grant to develop a novel low-energy system for atrial defibrillation
By: Stephanie Flynn Qun Sha, M.D., MBA, the director of clinical affairs, will be the Principal Investigator for the grant. This funded research will involve design, fabrication, and testing of electrical stimulation equipment capable of generating novel waveforms to further reduce the energy required to achieve atrial defibrillation. This grant follows the October, 2010 receipt of a Qualifying Therapeutic Discovery Project grant totaling $231,013. These funds were awarded to small firms that showed significant potential to produce new and cost-saving therapies, support U.S. jobs, and increase U.S. competitiveness. CardiaLen holds rights to its low-energy cardioversion technology under an exclusive global joint license from Washington University in St. Louis and Case Western Reserve University to develop and commercialize certain intellectual property developed by Professor Igor Efimov, Ph.D. This technology has the potential to provide pain-free cardioversion- CardiaLen is jointly located in St. Louis, MO, where it maintains its headquarters and clinical affairs office, and Minneapolis- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|